Stocks Near Their 52-Week High — Valuation View · Biological Products, (No Diagnostic Substances)
31 stocks match the Stocks Near Their 52-Week High screen. Stocks trading within 10% of their 52-week high — momentum/breakout candidates, largest first. Valuation columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–31 of 31
| AMGN | Amgen | $240.1B | 27.47 | 6.30 | 20.55 | 17.17 | 2.2% | 444.20 | +0.31% | 69K |
| GILD | Gilead Sciences | $187.5B | -57.87 | 6.16 | 15.85 | 58.98 | 2.1% | 151.21 | +1.09% | 186K |
| RVMD | Revolution Medicines, Inc. | $45.2B | -25.55 | — | 17.34 | 55.41 | — | 210.79 | +0.76% | 72K |
| BIIB | Biogen | $33.1B | 24.16 | 3.34 | 1.78 | 9.80 | — | 224.49 | +0.78% | 32K |
| EXEL | Exelixis, Inc. | $14.7B | 17.03 | 6.02 | 7.95 | 52.06 | — | 59.13 | +1.00% | 116K |
| HALO | Halozyme Therapeutics, Inc. | $12.6B | 30.39 | 7.55 | 87.56 | 77.04 | — | 110.73 | +1.01% | 90K |
| TECH | Bio-Techne | $11.4B | 62.48 | 9.35 | 5.39 | 42.93 | 0.4% | 72.46 | +0.21% | 124K |
| KRYS | Krystal Biotech, Inc. | $11.0B | 45.52 | 24.95 | 8.09 | 25.70 | — | 371.35 | +0.58% | 14K |
| APGE | Apogee Therapeutics, Inc. | $10.2B | -34.57 | — | — | 96.40 | — | 135.08 | +0.04% | 89K |
| KYMR | Kymera Therapeutics, Inc. | $9.7B | -32.51 | — | 6.45 | 78.26 | — | 117.15 | -1.24% | 40K |
| PCVX | Vaxcyte, Inc. | $9.1B | -8.56 | — | 3.30 | 49.73 | 0.0% | 61.22 | -0.62% | 43K |
| SRRK | Scholar Rock Holding Corp | $6.8B | -16.66 | — | 26.83 | 15.58 | — | 55.91 | -0.42% | 48K |
| CGON | Cg Oncology, Inc. | $6.6B | -29.36 | 1057.62 | 6.40 | 335.45 | — | 74.31 | -0.41% | 31K |
| IOVA | Iovance Biotherapeutics, Inc. | $4.0B | -13.77 | 12.27 | 5.42 | 35.99 | — | 8.80 | +2.09% | 641K |
| ADPT | Adaptive Biotechnologies Corp | $3.9B | -61.41 | 12.73 | 27.44 | 23.08 | — | 24.57 | -0.34% | 108K |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.6B | -78.48 | 6.02 | 10.52 | 17.83 | 0.0% | 83.12 | +0.41% | 43K |
| BCRX | Biocryst Pharmaceuticals Inc | $2.6B | -6.71 | 2.74 | — | 16.65 | — | 10.10 | -0.79% | 151K |
| REPL | Replimune Group, Inc. | $1.4B | -4.85 | — | 13.63 | 7.77 | — | 15.28 | -4.32% | 50K |
| CGEM | Cullinan Therapeutics, Inc. | $1.4B | -6.97 | — | 4.43 | 18.13 | — | 22.16 | -0.81% | 19K |
| ODTX | Odyssey Therapeutics, Inc. | $1.3B | — | — | 3.01 | 15.45 | — | 26.38 | -0.90% | 11K |
| ATTO | Attovia Therapeutics, Inc. | $1.2B | — | — | — | 35.22 | — | 25.33 | +3.56% | 23K |
| SLDB | Solid Biosciences Inc. | $1.1B | -5.39 | 138.04 | 2.99 | 7.01 | — | 10.42 | +1.36% | 71K |
| CADL | Candel Therapeutics, Inc. | $992M | -11.20 | 7933.44 | 7.86 | 4.92 | — | 12.96 | -1.67% | 30K |
| AGEN | AGENUS INC | $371M | 4.03 | 2.79 | — | 19.77 | — | 8.23 | +1.86% | 37K |
| IKT | Inhibikase Therapeutics, Inc. | $350M | -5.78 | — | 2.28 | 11.22 | — | 2.51 | +0.40% | 46K |
| ACOG | Alpha Cognition Inc. | $200M | -8.55 | — | 3.78 | 4.84 | — | 9.20 | -1.23% | 4K |
| INMB | Inmune Bio, Inc. | $63M | -3.44 | 1265.57 | 3.11 | 3.44 | — | 2.28 | -3.39% | 9K |
| CRDL | Cardiol Therapeutics Inc. | — | — | — | — | — | — | 2.15 | -0.23% | 66K |
| ARGX | Argenx Se | — | — | — | — | — | — | 1053.32 | -0.21% | 8K |
| IMCR | Immunocore Holdings Plc | — | — | — | — | — | — | 37.64 | +0.90% | 16K |
| FENC | FENNEC PHARMACEUTICALS INC. | — | — | — | — | — | — | 12.54 | +1.70% | 9K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.